Clinical Trials in Cleveland

Showing 6141-6160 of 15,050 trials

Safety and Efficacy of Nyxol (0.75% Phentolamine Ophthalmic Solution) to Reverse Pharmacologically-Induced Mydriasis

NCT04620213

The objectives of this study are: * To evaluate the efficacy of Nyxol to expedite the reversal of pharmacologically-induced mydriasis across multiple mydriatic agents with an emphasis on phenylephrine * To evaluate the efficacy of Nyxol to return subjects to baseline accommodation after worsening (with cycloplegic agents tropicamide and Paremyd) * To evaluate the safety of Nyxol * To evaluate any additional benefits of the reversal of pharmacologically-induced mydriasis

MydriasisDilation

Ocuphire Pharma, Inc.185 participantsStarted Nov 2020

Newport Beach, California, United States • San Diego, California, United States • Longwood, Florida, United States +9 more locations

COMPLETEDPhase 3< 1 mile

Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency

NCT00709865

The purpose of the current study is to assess the safety and tolerability of intravenous tonapofylline.

Renal InsufficiencyCongestive Heart Failure

Biogen420 participantsStarted Jul 2008

Huntsville, Alabama, United States • Mobile, Alabama, United States • Fort Smith, Arkansas, United States +186 more locations

Safety and Efficacy of Nyxol (0.75% Phentolamine Ophthalmic Solution) to Reverse Pharmacologically-Induced Mydriasis

Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency

Find Trials by Condition in Cleveland

Observation or Radiation Therapy in Treating Patients With Grade I, Grade II, or Grade III Meningioma

Addressing Dementia Via Agitation-Centered Evaluation

Real World Evaluation of the Effectiveness of AZD7442 for Prevention of SARS-CoV-2

INCAGN01876 in Combination With Immunotherapy in Participants With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Study of Ipatasertib or Apitolisib With Abiraterone Acetate Versus Abiraterone Acetate in Participants With Castration-Resistant Prostate Cancer Previously Treated With Docetaxel Chemotherapy

Study of the Safety and Efficacy of PRX-102 Compared to Agalsidase Beta on Renal Function

Study of Safety and Efficacy of Multiple Doses of CFZ533 in Two Distinct Populations of Patients With Sjogren's Syndrome

Study of Sotatercept for the Treatment of Chemotherapy Induced Anemia in Patients With Metastatic Breast Cancer (MK-7962-012)

Dose-Ranging Efficacy and Safety Study of Topical Rapamycin Cream for Facial Angiofibroma Associated With Tuberous Sclerosis Complex

PCI Treatment/Gemcitabine & Chemotherapy vs Chemotherapy Alone in Patients With Inoperable Extrahepatic Bile Duct Cancer

Multi-Center Pilot Study of Cutera truSculpt Device

Multi-Center Pilot Study of truSculpt Device

Primary Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

An add-on Study to the FIGARO-DKD Study Called FIGARO-BM to Learn About the Link Between Biomarkers (Substances in the Blood Used as Indicators of Biological Processes, Disease Processes or Responses to Medication) and Finerenone in FIGARO-DKD Participants

Efficacy and Safety of Orally Administered BBT-401-1S in Subjects With Ulcerative Colitis

Study of a Novel Laser for Skin Rejuvenation

Kappa Opioid Receptor Antagonism for the Tx of AUD and Comorbid PTSD

PEP on a Skin Graft Donor Site Wound